Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Maxitech Pharma (Pvt) Ltd.

Pharmaceutical manufacturer · Pakistan

Database-driven profile Portfolio, price and regulatory-source intelligence derived from MedInfoBase records.
ShareSend this page
Regulatory & corporate identity

Company profile

Not yet verified
Company type
Pharmaceutical manufacturer
DRAP-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000851 118 linked products · source seen 10 Aug 2026 View source ↗
Location intelligence

Company location

Google Maps
Exact site not yet verified

MedInfoBase will not invent a factory or office location. The map appears after a sourced address, Place ID or verified embed URL is added.

Open in Google Maps ↗ The Google Maps search link uses the company name and available city/country context; it is not presented as a verified premises pin.
Intelligence snapshot

Portfolio at a glance

Not sales data · current MedInfoBase database view
Rx118product presentations
G45generic molecules
DF10dosage-form groups
TA10therapeutic areas
PKR118current price records
REG98registration numbers
Data coverage

How complete is this profile?

Current price coverage100%
products with a current official price
Source-linked coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage92%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixMaxitech Pharma (Pvt) Ltd.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/maxitech-pharma-pvt-ltdGenerated 10 Aug 2026Anti-infectives88 · 75%Dermatology8 · 7%Cardiovascular6 · 5%Vitamins, minerals & nutrition3 · 3%Fluids & supportive care3 · 3%Oncology & immunology3 · 3%Gastrointestinal & hepatology3 · 3%Other therapeutic areas4 · 3%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioMaxitech Pharma (Pvt) Ltd.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/maxitech-pharma-pvt-ltdGenerated 10 Aug 2026118presentationsTablet42 · 36%Injection31 · 26%Capsule18 · 15%Suspension9 · 8%Cream5 · 4%Infusion4 · 3%Other forms9 · 8%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent-Market Price Position

Shows whether safely comparable products are below, near or above the market median unit price.

Equivalent-Market Price PositionMaxitech Pharma (Pvt) Ltd.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/maxitech-pharma-pvt-ltdGenerated 10 Aug 2026108comparable productsBelow market median38 · 35%Near market median53 · 49%Above market median17 · 16%Company median price position-0.8%Lowest-price equivalents12Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsMaxitech Pharma (Pvt) Ltd.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/maxitech-pharma-pvt-ltdGenerated 10 Aug 2026Neutro Pharma (Pvt.) Ltd.,31 shared69% overlapPharmasol (Pvt) Ltd.29 shared64% overlapEpharm Laboratories29 shared64% overlapM/s. Genix Pharma (Pvt) Ltd.28 shared62% overlapValor Pharmaceuticals28 shared62% overlapNovaMed Pharmaceuticals(Pvt.)Ltd28 shared62% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives88 products · 75%
Dermatology8 products · 7%
Cardiovascular6 products · 5%
Vitamins, minerals & nutrition3 products · 3%
Fluids & supportive care3 products · 3%
Oncology & immunology3 products · 3%
Gastrointestinal & hepatology3 products · 3%
Endocrine & metabolic2 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antivirals18 products · 15%
Third-generation cephalosporins17 products · 14%
Fluoroquinolone antibacterials9 products · 8%
Macrolide antibacterials8 products · 7%
Antifungals6 products · 5%
Oxazolidinone antibacterials5 products · 4%
Antimalarials5 products · 4%
First-generation cephalosporins4 products · 3%
Formulation footprint

Dosage forms

Tablet42 products
Injection31 products
Capsule18 products
Suspension9 products
Cream5 products
Infusion4 products
Lotion3 products
Drops2 products
Ointment2 products
Sachet2 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 MaxribRibavirin 15presentations 400 mg, 500 mg, 600 mg · Tablet #2 KOCEFANCeftriaxone 7presentations 1 g, 2 g, 250 mg, 500 mg · Injection #3 LinzoLinezolid 5presentations 100 mg/5 mL, 200 mg /100 mL, 400 mg, 600 mg · Suspension, Injection, Tablet #4 ReflazinCiprofloxacin 5presentations 100 mg/50 mL, 200 mg/100 mL, 250 mg, 250 mg/5 mL · Infusion, Tablet #5 XUCLAMINClarithromycin 5presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Tablet, Suspension #6 MixoCefixime 4presentations 100 mg/5 mL, 200 mg, 200 mg/5 mL, 400 mg · Suspension, Capsule
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median3835% of comparable products
Near market median53within ±5% of median
Above market median1716% of comparable products
Lowest-price equivalents12ties included
Company median price position -0.8% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
MEFINTIN-EZ 80 80 mg + 480 mgArtemether + Lumefantrine · Tablet · 8's PKR 62.63/tablet-42.5% vs market median Obtrude 1.5 gCefuroxime · Injection · 1's PKR 206.49/vial/unit-39.6% vs market median MAXIZOLE Topical 2 %Miconazole · Cream · 20gm PKR 4.80/g-30.9% vs market median Glycocin 20 mg/2 mLGentamicin · Injection · 2mlx5's PKR 7.77/mL-27.3% vs market median POTSART 50 mgLosartan · Tablet · 20's PKR 15.18/tablet-26.7% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 31shared generics Pharmasol (Pvt) Ltd.251 products · 101 generics 29shared generics Epharm Laboratories144 products · 67 generics 29shared generics M/s. Genix Pharma (Pvt) Ltd.290 products · 97 generics 28shared generics Valor Pharmaceuticals218 products · 97 generics 28shared generics NovaMed Pharmaceuticals(Pvt.)Ltd185 products · 62 generics 28shared generics
Regulatory & price activity

Observed database signals

Registration numbers98
Price-history records137
Products with price history9
Source records with multiple versions0
Latest MedInfoBase verification9 Aug 2026
Latest effective price date27 Jul 2026
Latest source observation10 Aug 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Sponsored company campaign area · advertising must be clearly disclosed
Complete company portfolio

Products and presentations

118 results
Reset
BrandGenericStrengthFormPackRegistrationOfficial priceUnit priceMarket position
Bactocan Fluconazole 150 mg Capsule 4's 083723 PKR 995.04 PKR 248.76/capsule 5% below median
Bactocan Fluconazole 50 mg/5 mL Suspension 35ml 083751 PKR 418.88 PKR 11.97/mL Near median
Bactocan Fluconazole 150 mg Capsule 1's 083723 PKR 275.27 PKR 275.27/capsule Near median
Cefenas Cephalexin 250 mg/5 mL Suspension 60ml 096380 PKR 188.05 PKR 3.13/mL Near median
Cefenas Cephalexin 500 mg Capsule 12's 096080 PKR 388.30 PKR 32.36/capsule 5% above median
Cefenas Cephalexin 125 mg/5 mL Suspension 60ml 096379 PKR 108.94 PKR 1.82/mL Near median
CHOLCE-D Cholecalciferol 50,000 IU Capsule 100’s 118149 PKR 250.52 PKR 2.51/capsule No comparator
CHOLCE-D Cholecalciferol 5 mg Injection 1mlx1's 096046 PKR 213.57 PKR 213.57/mL 14% above median
Dimed Betamethasone dipropionate 0.05% Cream 15gm 083737 PKR 72.44 PKR 4.83/g Near median
Dimed Betamethasone dipropionate 0.05 % Lotion 20ml 083738 PKR 67.82 PKR 3.39/mL 15% above median
Dimed Betamethasone dipropionate 0.05 % Lotion 60ml 083738 PKR 149.60 PKR 2.49/mL 16% below median
Dimed ointmant Betamethasone 0.05% Ointment 15gm 095187 PKR 72.44 PKR 4.83/g Near median
E-Bal Oral rehydration salts (ORS) NaCl 2.6 g + trisodium citrate dihydrate 2.9 g + KCl 1.5 g + dextrose anhydrous 13.5 g Sachet 1's 083748 PKR 19.95 PKR 19.95/sachet No comparator
E-Bal Sodium chloride 2.60 g Sachet 20's 083748 PKR 398.94 PKR 19.95/sachet 23% below median
FOTAXIME Cefotaxime 1 g IV/IM injection 1’s 096382 PKR 285.88 PKR 285.88/vial/unit Near median
FOTAXIME Cefotaxime 250 mg IV/IM injection 1’s 096383 PKR 105.47 PKR 105.47/vial/unit Near median
FOTAXIME Cefotaxime 500 mg IV/IM injection 1’s 096384 PKR 158.95 PKR 158.95/vial/unit Near median
Glycocin Gentamicin 80 mg/2 mL Injection 2mlx5's 096051 PKR 155.32 PKR 15.53/mL Near median
Glycocin Gentamicin 20 mg/2 mL Injection 2mlx5's 096049 PKR 77.66 PKR 7.77/mL 27% below median
Glycocin Gentamicin 40 mg/2 mL Injection 2mlx5's 096050 PKR 116.49 PKR 11.65/mL Near median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.